Crossject Share Price Deutsche Boerse AG
Equities
74C
FR0011716265
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.826 EUR | +2.70% | +16.16% | -59.78% |
07-10 | Markets Powered by Alternating Current | |
07-10 | Crossject Gets EUR7 Million Public Funding for New Epinephrine Product | MT |
Sales 2024 * | 8.1M 8.83M 681M | Sales 2025 * | 53M 57.75M 4.45B | Capitalization | 84.68M 92.28M 7.12B |
---|---|---|---|---|---|
Net income 2024 * | -10M -10.9M -840M | Net income 2025 * | 22M 23.97M 1.85B | EV / Sales 2024 * | 13.1 x |
Net Debt 2024 * | 21.7M 23.65M 1.82B | Net Debt 2025 * | 5.1M 5.56M 429M | EV / Sales 2025 * | 1.69 x |
P/E ratio 2024 * |
-8.24
x | P/E ratio 2025 * |
3.96
x | Employees | 105 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.12% |
1 day | +2.70% | ||
1 week | +16.16% | ||
Current month | +12.72% | ||
1 month | +5.18% | ||
3 months | -4.40% | ||
6 months | -66.31% | ||
Current year | -59.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 07/08/01 | |
Olivier Giré
PRN | Corporate Officer/Principal | - | 31/12/15 |
General Counsel | - | 31/12/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Teper
BRD | Director/Board Member | 64 | 06/06/23 |
Eric Nemeth
BRD | Director/Board Member | 65 | - |
Philippe Monnot
CHM | Chairman | 65 | - |
Date | Price | Change |
---|---|---|
16/07/24 | 1.826 | +2.70% |
15/07/24 | 1.778 | -0.11% |
12/07/24 | 1.78 | -0.45% |
11/07/24 | 1.788 | -3.35% |
10/07/24 | 1.85 | +17.68% |
Delayed Quote Deutsche Boerse AG, July 16, 2024 at 07:02 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.50% | 261M |
- Stock Market
- Equities
- ALCJ Stock
- 74C Stock